Systematic review and meta-analysis of anti-CD20 treatments in patients with COVID-19: an assessment of severe illness and mortality outcomes
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Link
https://link.springer.com/content/pdf/10.1007/s10787-023-01349-z.pdf
Reference25 articles.
1. Andersen KM, Bates BA, Rashidi ES, Olex AL, Mannon RB, Patel RC et al (2022) Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative. Lancet Rheumatol 4(1):e33–e41
2. Avouac J, Drumez E, Hachulla E, Seror R, Georgin-Lavialle S, Mahou SE et al (2021) COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study. Lancet Rheumatol 3(6):e419–e426
3. Boteanu A, Leon L, Esteban SP, Rubio ER, Pascual MP, Bonilla G et al (2022) Severe COVID-19 in patients with immune-mediated rheumatic diseases: a stratified analysis from the SORCOM multicenter registry. Mod Rheumatol. https://doi.org/10.1093/mr/roac148
4. Chevalier K, Genin M, Jean TP, Avouac J, Flipo R, Georgin-Lavialle S et al (2023) CovAID: identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases. Front Med 10:1152587
5. Cruz-Machado AR, Barreira SC, Bandeira M, Veldhoen M, Gomes A, Serrano M et al (2022) Risk factors for infection, predictors of severe disease, and antibody response to COVID-19 in patients with inflammatory rheumatic diseases in Portugal-A multicenter, nationwide study. Front Med 9:901817
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3